Paradigm Biopharmaceuticals Ltd.ASX: PAR

PAR Reports Phase 3 Clinical Trial Update

Jul 4, 2023 at 2:40 AM UTC · Issued by Paradigm Biopharmaceuticals Ltd.

Paradigm Biopharmaceuticals Ltd has released a press release.

View Attachment